Paulo J.C. Lin
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 20
- Advanced biosensing and bioanalysis techniques 11
- Ion channel regulation and function 4
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 9
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- Biomaterials top 5%
- Animal Science and Zoology top 2%
- Animal Virus Infections Studies 5
-
- Virus-based gene therapy research 4
-
- MicroRNA in disease regulation 4
- Co-authors
- Ying K. TamPieter R. CullisSam ChenYuen Yi C. TamAlex K. K. LeungNathan M. BelliveauJens HuftCarl L. Hansen
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Paulo J.C. Lin
45 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 2.4k
- Infectious Diseases 579
- Immunology 571
- Biomaterials 332
- Animal Science and Zoology 216
Countries citing papers authored by Paulo J.C. Lin
This map shows the geographic impact of Paulo J.C. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulo J.C. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulo J.C. Lin more than expected).
Fields of papers citing papers by Paulo J.C. Lin
This network shows the impact of papers produced by Paulo J.C. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulo J.C. Lin. The network helps show where Paulo J.C. Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paulo J.C. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 72 | |
| 3 | Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in micebreakdown → | 2023 | 87 |
| 4 | 2023 | 2 | |
| 5 | 2022 | 27 | |
| 6 | 2022 | 34 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 75 | |
| 10 | 2021 | 60 | |
| 11 | 2020 | 339 | |
| 12 | 2019 | 69 | |
| 13 | 2016 | 49 | |
| 14 | 2015 | 57 | |
| 15 | 2015 | 189 | |
| 16 | 2014 | 47 | |
| 17 | 2014 | 127 | |
| 18 | 2012 | 36 | |
| 19 | 2011 | 65 | |
| 20 | 2006 | 17 |
About Paulo J.C. Lin
Paulo J.C. Lin is a scholar working on Immunology, Virology and Infectious Diseases, having authored 46 papers that have together received 3.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (20 papers), Advanced biosensing and bioanalysis techniques (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Immunotherapy and Immune Responses (8 papers), Animal Virus Infections Studies (5 papers), Virus-based gene therapy research (4 papers), MicroRNA in disease regulation (4 papers) and Ion channel regulation and function (4 papers). The work is most often cited by research in Molecular Biology (2.4k citations), Infectious Diseases (579 citations) and Immunology (571 citations). Paulo J.C. Lin has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Ying K. Tam, Pieter R. Cullis, Sam Chen, Yuen Yi C. Tam, Alex K. K. Leung, Nathan M. Belliveau, Jens Huft, Carl L. Hansen, Molly M. H. Sung and Muthiah Manoharan. Their work appears in journals such as Nature, Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.